ADHERTENCE AND COMPLIANCE TO TREATMENTS

Size: px
Start display at page:

Download "ADHERTENCE AND COMPLIANCE TO TREATMENTS"

Transcription

1 ADHERTENCE AND COMPLIANCE TO TREATMENTS Sobhi DADA, MD, FACC, FESC Consultant cardiology Hammoud Hospital- University medical center Saida, Lebanon

2 Adherence Mosby s Medical Dictionary defines adherence as the process in which a person follows rules, guidelines, or standards, especially as patients follow a prescription and recommendations for a regimen of care

3

4 Medication adherence The degree to which the person s behavior corresponds with the agreed recommendations from a health care provider. World Health Organization

5

6 Chronic Care Model

7 Global Medication Adherence is 50%

8 Medication adherence 22% of U.S. patients take less of the medication than is prescribed American Heart Association: Statistics you need to know. Accessed November 21, 2007.

9 Percent of patients continually refilling Rx Adherence to statins after two years, by condition 50% 40% 30% 20% 10% 0% 40% Acute coronary syndrome 36% Chronic coronary artery disease 24% Primary prevention Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002;288:

10 Why adherence matters Of all medication-related hospital admissions in the United States, 33 to 69 percent are due to poor medication adherence, with a resultant cost of approximately $100 billion a year. Results of failure to adhere to prescribed medications: Increased hospitalization Poor health outcomes Increased costs Decreased quality of life Patient death Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288:

11 Annual per-patient health care costs Poor adherence increases total health care costs Hypertensive Patients and Total Annual Costs $12,000 $10,000 $8,000 $6,000 $4,000 $2,000 $0 $4,850 Received meds, 100% compliant $6,400 Purchased some, but took all purchased $10,500 Purchased some, taken irregularly Smith DL. The effect of patient noncompliance on health care costs. Medical Interface 1993:April; 74-84

12 Why don t patients adhere to their medication therapy? Complex therapies Side Effects Failure to understand the need for the medication High out-of-pocket costs Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288:

13 Overcoming barriers to adherence Health plan pays member copay Reduces member out-of pocket costs Emphasizes the importance of continuing therapy Education and outreach Explains the need for medication therapy Breaks down complex therapies into manageable parts Offers strategies for coping with side effects Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288:

14 Investment in medication adherence can lead to dramatic reductions in overall cost of care Average health care expenditures per year ($) $10,000 $55 $8,000 $165 $285 $404 $6,000 $763 $8,812 $4,000 $6,959 $6,237 $5,887 $2,000 $3,808 $0 1-19% 20-39% 40-59% 60-79% % Diabetes Medication Level of Adherence (% days supply/year) Rx $ Medical $ Outcome is significantly higher than outcome for % adherence group (P<0.05). Differences were tested for medical cost and hospitalization risk. Sokol M et al. Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost. Medical Care. Volume 43, Number 6, June 2005

15

16

17

18

19

20 WHO s Five Dimensions of Adherence

21 Self-Management

22

23

Improving Adherence to Chronic Medications: The Physicians Role and How 340b Can Help

Improving Adherence to Chronic Medications: The Physicians Role and How 340b Can Help Improving Adherence to Chronic Medications: The Physicians Role and How 340b Can Help William Shrank MD MSHS Division of Pharmacoepidemiology & Pharmacoeconomics Harvard Medical School wshrank@partners.org

More information

CLINICAL. Determinants of Compliance With Statin Therapy and Low-Density Lipoprotein Cholesterol Goal Attainment in a Managed Care Population

CLINICAL. Determinants of Compliance With Statin Therapy and Low-Density Lipoprotein Cholesterol Goal Attainment in a Managed Care Population Determinants of Compliance With Statin Therapy and Low-Density Lipoprotein Cholesterol Goal Attainment in a Managed Care Population Jennifer S. Schultz, PhD; John C. O Donnell, PhD; Ken L. McDonough, MD;

More information

As a result of its prevalence and cost, cardiovascular disease

As a result of its prevalence and cost, cardiovascular disease Benjamin J. Ansell, MD, FACP/FACC ABSTRACT BACKGROUND: Cardiovascular disease is characterized by significant prevalence and cost in the managed care setting. Despite overwhelming evidence in favor of

More information

Disclosure. Learning Objectives 6/4/2014. Medication Adherence: Challenges and Opportunities

Disclosure. Learning Objectives 6/4/2014. Medication Adherence: Challenges and Opportunities Medication Adherence: Challenges and Opportunities Jessica W. Skelley, Pharm D., BCACP Assistant Professor of Pharmacy Practice McWhorter School of Pharmacy, Samford University jmwhalen@samford.edu Disclosure

More information

RESEARCH. Monitoring adherence to drug treatment by using change in cholesterol concentration: secondary analysis of trial data

RESEARCH. Monitoring adherence to drug treatment by using change in cholesterol concentration: secondary analysis of trial data 1 Screening and Test Evaluation Program (STEP), School of Public Health, University of Sydney, NSW 26, Australia 2 NHMRC Clinical Trials Centre, University of Sydney 3 Centre for Research in Evidence Based

More information

MEDICATION ADHERENCE: WE DIDN T ASK & THEY DIDN T TELL

MEDICATION ADHERENCE: WE DIDN T ASK & THEY DIDN T TELL MEDICATION ADHERENCE: WE DIDN T ASK & THEY DIDN T TELL JENNIFER BUSSELL MD FACP INSTITUTE FOR HEALTHCARE IMPROVEMENT 15 TH ANNUAL INTERNATIONAL SUMMIT ON IMPROVING PATIENT CARE IN THE OFFICE PRACTICE AND

More information

By 2030, the number of seniors in the United States

By 2030, the number of seniors in the United States Patient Characteristics and Medication Burden Affect Adherence Among Seniors Drug Trends R. Scott Leslie, MPH; Sara C. Erickson, PharmD; and Bimal V. Patel, PharmD, MS By 2030, the number of seniors in

More information

Understanding Your Patient Care Opportunity Report (PCOR)

Understanding Your Patient Care Opportunity Report (PCOR) Understanding Your Patient Care Opportunity Report (PCOR) Use your January/February 208 PCOR to help improve performance on Medicare Part D Clinical Star Ratings measures. Your January/February 208 Patient

More information

The important role of cholesterol in the development

The important role of cholesterol in the development Research Recherche The use of cholesterol-lowering medications after coronary revascularization James M. Brophy, Chantal Bourgault, Paul Brassard Abstract Background: In clinical trials, cholesterol-lowering

More information

Periodic Rosuvastatin or Atorvastatin Dosing Arrays (PRADA): Patient-Centered Practice

Periodic Rosuvastatin or Atorvastatin Dosing Arrays (PRADA): Patient-Centered Practice Drugs R D (2014) 14:221 225 DOI 10.1007/s40268-014-0061-9 ORIGINAL RESEARCH ARTICLE Periodic Rosuvastatin or Atorvastatin Dosing Arrays (PRADA): Patient-Centered Practice Theodore Christou Hesham R. Omar

More information

To Take or Not To Take?

To Take or Not To Take? To Take or Not To Take? Assessment Question How do the terms adherence & compliance differ? 1. The terms are synonymous 2.Adherence assumes collaboration between patient & provider while compliance suggests

More information

Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients y

Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients y pharmacoepidemiology and drug safety 2008; 17: 1189 1196 Published online 27 October 2008 in Wiley InterScience (www.interscience.wiley.com).1671 ORIGINAL REPORT Trends in adherence to secondary prevention

More information

CLINICAL. The Effect of Switching on Compliance and Persistence: The Case of Statin Treatment

CLINICAL. The Effect of Switching on Compliance and Persistence: The Case of Statin Treatment The Effect of Switching on Compliance and Persistence: The Case of Statin Treatment Patrick Thiebaud, PhD; Bimal V. Patel, PharmD; Michael B. Nichol, PhD; and David M. Berenbeim, MD Objective: To determine

More information

Getting Hypertension Under Control

Getting Hypertension Under Control Getting Hypertension Under Control Learning Objectives EXPLAIN the factors involved in patient medication non-adherence. OUTLINE the results of studies focusing on medication adherence issues in patients

More information

Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents

Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents Dennis T. Ko, MD, MSc, a,b Maria Chiu, MSc, b Helen Guo, MSc, b Peter

More information

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS Philip J. Schneider, MS, FASHP The University of Arizona College of Pharmacy Learning Objectives: Describe the medication-use system and all interdependent

More information

Economics of Reducing Out-of-Pocket Costs for Cardiovascular Preventive Services for Patients with High Blood Pressure and High Cholesterol

Economics of Reducing Out-of-Pocket Costs for Cardiovascular Preventive Services for Patients with High Blood Pressure and High Cholesterol s of Reducing Out-of-Pocket Costs for Cardiovascular Preventive Services for Patients with High Blood Pressure and High Cholesterol Summary Evidence Tables Study Author (Year) Bunting (2008) Prepost Incomplete

More information

Kidney Function and Long-Term Medication Adherence after Myocardial Infarction in the Elderly

Kidney Function and Long-Term Medication Adherence after Myocardial Infarction in the Elderly Article Kidney Function and Long-Term Medication Adherence after Myocardial Infarction in the Elderly Tara I. Chang,* Manisha Desai, Daniel H. Solomon, and Wolfgang C. Winkelmayer* Summary Background and

More information

Potential synergy between lipid-lowering and blood-pressure-lowering, and Single pill benefit in patient s adherence

Potential synergy between lipid-lowering and blood-pressure-lowering, and Single pill benefit in patient s adherence Potential synergy between lipid-lowering and blood-pressure-lowering, and Single pill benefit in patient s adherence Park, Chang Gyu Korea University Guro Hospital ASCOT-BPLA and LLA Primary Objectives

More information

Moving the Needle: How Are We Doing with Patient Adherence to Drug Therapy?

Moving the Needle: How Are We Doing with Patient Adherence to Drug Therapy? Moving the Needle: How Are We Doing with Patient Adherence to Drug Therapy? 2018 Patient Adherence Influence Report By Mike Occhipinti and Linda Morini 2018 Syneos Health. All rights reserved. MOVING THE

More information

Persistence With Lipid-Lowering Therapy: Influence of the Type of Lipid-Lowering Agent and Drug Benefit Plan Option in Elderly Patients

Persistence With Lipid-Lowering Therapy: Influence of the Type of Lipid-Lowering Agent and Drug Benefit Plan Option in Elderly Patients ORIGINAL RESEARCH Persistence With Lipid-Lowering Therapy: Influence of the Type of Lipid-Lowering Agent and Drug Benefit Plan Option in Elderly Patients SUSAN M. ABUGHOSH, PhD; STEPHEN J. KOGUT, RPh,

More information

Leveraging Information Technology for Evidence-Based Design. December 15, 2005

Leveraging Information Technology for Evidence-Based Design. December 15, 2005 Leveraging Information Technology for Evidence-Based Design December 15, 2005 Introduction ActiveHealth Management Technology Evidence Based Formulary Program Lessons Learned 2 ActiveHealth Management

More information

Cost-Related Medication Underuse: Prevalence Among Hospitalized Managed Care Patients

Cost-Related Medication Underuse: Prevalence Among Hospitalized Managed Care Patients ORIGINAL RESEARCH Cost-Related Medication Underuse: Prevalence Among Hospitalized Managed Care Patients Niteesh K. Choudhry, MD, PhD 1 *, Uzaib Y. Saya, BA 1, William H. Shrank, MD, MSHS 1, Jeffrey O.

More information

SLEEP SOLUTION. AIM Insights

SLEEP SOLUTION. AIM Insights SLEEP SOLUTION AIM Insights Protecting sleep health: The cost when Americans ignore sleep disorder treatment How AIM is leveraging data to identify gaps in clinical care and reduce health care spending

More information

Intervention to improve adherence to Type 2 Diabetes mellitus subjects in rural teaching hospital

Intervention to improve adherence to Type 2 Diabetes mellitus subjects in rural teaching hospital Available online at wwwscholarsresearchlibrarycom Scholars Research Library Der Pharmacia Lettre, 2016, 8 (1):361-367 (http://scholarsresearchlibrarycom/archivehtml) ISSN 0975-5071 USA CODEN: DPLEB4 Intervention

More information

Prescription Switching and Reduced LDL-C Goal Attainment

Prescription Switching and Reduced LDL-C Goal Attainment Prescription Switching and Reduced LDL-C Goal Attainment JoAnne M. Foody, MD, FACC, FAHA Brigham and Women's Hospital, Boston, MA Disclosures Consultant for Merck and Pfizer Why Address Adherence? Increasing

More information

Dyslipidemia Treatment in 2016 Novel Agents Combination Therapies Statin Intolerance

Dyslipidemia Treatment in 2016 Novel Agents Combination Therapies Statin Intolerance Dyslipidemia Treatment in 2016 Novel Agents Combination Therapies Statin Intolerance Hani Sabbour MD FACC FHRS Clinical Assistant Professor of Cardiology Brown University Rhode Island USA Consultant Cardiology

More information

Efforts to redesign the healthcare system are increasingly focused

Efforts to redesign the healthcare system are increasingly focused A Blueprint for Pharmacy Benefit Managers to Increase Value William H. Shrank, MD, MSHS; Michael E. Porter, PhD, MBA; Sachin H. Jain, MD, MBA; and Niteesh K. Choudhry, MD, PhD Managed Care & ealthcare

More information

An advisory committee to the U.S. Food and Drug

An advisory committee to the U.S. Food and Drug Perspective Over-the-Counter Statins Niteesh K. Choudhry, MD, PhD, and Jerry Avorn, MD In late 2004, the British government decided to allow a lipidlowering agent to be sold as an over-the-counter medication.

More information

Concordance of Pharmacist Assessment of Medication Nonadherence With a Self-Report Medication Adherence Scale

Concordance of Pharmacist Assessment of Medication Nonadherence With a Self-Report Medication Adherence Scale Chapman University Chapman University Digital Commons Pharmacy Faculty Articles and Research School of Pharmacy 10-13-2014 Concordance of Pharmacist Assessment of Medication Nonadherence With a Self-Report

More information

Poor blood pressure control substantially increases the risk of

Poor blood pressure control substantially increases the risk of Effect of Patient Comorbidities on Filling of Antihypertensive Prescriptions Tara Lagu, MD, MPH; Mark G. Weiner, MD; Susan Eachus, PhD; Simon S. K. Tang, MPH; J. Sanford Schwartz, MD; and Barbara J. Turner,

More information

Calculating Risk for Primary Prevention of Cardiovascular Disease (CVD)

Calculating Risk for Primary Prevention of Cardiovascular Disease (CVD) Calculating Risk for Primary Prevention of Cardiovascular Disease (CVD) 2. Welcome by Stacey Sheridan, MD, MPH Hello. My name is Stacey Sheridan, and I m here as your partner in Heart Health Now. The North

More information

OR OTHER RELATIONSHIP(S) DISCLOSURE:

OR OTHER RELATIONSHIP(S) DISCLOSURE: Gregory Roth, MD DISCLOSURE DECLARATION Medication Adherence in Cardiovascular Disease: Drugs Don t Work in Patients Who Don t Take Them FINANCIAL OR OTHER RELATIONSHIP(S) DISCLOSURE: St. Charles Medical

More information

IMPACT OF PILL BURDEN AND SOCIO-ECONOMIC STATUS OF PATIENTS ON ADHERENCE TO PHARMACOLOGIC THERAPY IN ELDERLY

IMPACT OF PILL BURDEN AND SOCIO-ECONOMIC STATUS OF PATIENTS ON ADHERENCE TO PHARMACOLOGIC THERAPY IN ELDERLY The West London Medical Journal 2014 Vol 6 No 1 pp 23-28 IMPACT OF PILL BURDEN AND SOCIO-ECONOMIC STATUS OF PATIENTS ON ADHERENCE TO PHARMACOLOGIC THERAPY IN ELDERLY Anil Kumar Jeetendra Kumar Balakrisnan

More information

How pharmacy and retail health can support health and wellness. Nancy Gagliano Chief Medical Officer, MC September, 2014

How pharmacy and retail health can support health and wellness. Nancy Gagliano Chief Medical Officer, MC September, 2014 How pharmacy and retail health can support health and wellness Nancy Gagliano Chief Medical Officer, MC September, 2014 2 An important decision for public health Current Health Care Challenges The State

More information

Improving Medication Adherence through Collaboration between Colleges of Pharmacy and Community Pharmacies

Improving Medication Adherence through Collaboration between Colleges of Pharmacy and Community Pharmacies Improving Medication Adherence through Collaboration between Colleges of Pharmacy and Community Pharmacies Megan Willson, PharmD, BCPS; Catrina Schwartz, PharmD, BS; Jennifer Robinson, PharmD Spokane,

More information

Adherence and persistence with prescribed chronic medications

Adherence and persistence with prescribed chronic medications RESEARCH Impact of Appointment-Based Medication Synchronization on Existing Users of Chronic Medications David Holdford, RPh, MS, PhD, FAPhA, and Kunal Saxena, BS, MS ABSTRACT BACKGROUND: Appointment-based

More information

Oral Self Care By P. Weinstein;T. Getz

Oral Self Care By P. Weinstein;T. Getz Oral Self Care By P. Weinstein;T. Getz Behaviour management guidelines - Jul 28, 2015 recognizes that, in providing oral health care for infants, and self-confident in the dental 15. Weinstein P, Getz

More information

The Nanos Survey on Drug Affordability is Flawed. Here s Why.

The Nanos Survey on Drug Affordability is Flawed. Here s Why. The Nanos Survey on Drug Affordability is Flawed. Here s Why. Michael Law (michael.law@ubc.ca) and Ashra Kolhatkar March 6, 2018 Background Last month, with colleagues we published the largest study to

More information

Chronic Disease Management. Mary Rouleau, RN, RD, CDE Condition Management RN The Center

Chronic Disease Management. Mary Rouleau, RN, RD, CDE Condition Management RN The Center Chronic Disease Management Mary Rouleau, RN, RD, CDE Condition Management RN The Center Chronic Diseases Conditions that: last 1 year or more require ongoing medical attention limit activities of daily

More information

Hypertension and the Challenge of Adherence. Geneva Clark Briggs, Pharm.D., BCPS

Hypertension and the Challenge of Adherence. Geneva Clark Briggs, Pharm.D., BCPS Hypertension and the Challenge of Adherence Geneva Clark Briggs, Pharm.D., BCPS Outline Brief overview of HTN and pharmacologic therapies Role of pharmacists in collaboration with patients and physicians

More information

Leverage Healthcare Technology Applications to Improve Primary Nonadherence.

Leverage Healthcare Technology Applications to Improve Primary Nonadherence. Leverage Healthcare Technology Applications to Improve Primary Nonadherence. Page 2 Medication adherence starts with assessing a patient s opportunity for having positive outcomes on a specific therapy.

More information

Improve the Adherence, Save the Life

Improve the Adherence, Save the Life Improve the Adherence, Save the Life Park, Chang Gyu Korea University Guro Hospital Cardiovascular Center Seoul, Korea Modifiable CVD Risk Factors Obesity BMI Hypertension Cholesterol LDL HDL Diabetes

More information

Should All Patients Be Treated with Ace-inh /ARB after STEMI with Preserved LV Function?

Should All Patients Be Treated with Ace-inh /ARB after STEMI with Preserved LV Function? Should All Patients Be Treated with Ace-inh /ARB after STEMI with Preserved LV Function? Avi Shimony, MD, FESC Cardiology Division Soroka University Medical Center Ben-Gurion University, Beer-Sheva Disclosure

More information

PDE File Medication Utilization; Medication Possession Ratio. Kyoungrae Jung, Ph.D. Assistant Professor Penn State University

PDE File Medication Utilization; Medication Possession Ratio. Kyoungrae Jung, Ph.D. Assistant Professor Penn State University PDE File Medication Utilization; Medication Possession Ratio Kyoungrae Jung, Ph.D. Assistant Professor Penn State University Outline PDE variables related to medication utilization Measures of medication

More information

STATINS (3-HYDROXY-3-METHYLglutaryl

STATINS (3-HYDROXY-3-METHYLglutaryl ORIGINAL CONTRIBUTION Adherence With Statin Therapy in Elderly Patients With and Without Acute Coronary Syndromes Cynthia A. Jackevicius, BScPhm, MSc, FCSHP Muhammad Mamdani, PharmD, MA, MPH Jack V. Tu,

More information

16 th Annual IHA Stakeholders Meeting Session 2C

16 th Annual IHA Stakeholders Meeting Session 2C 16 th Annual IHA Stakeholders Meeting Session 2C September 19, 2017 Hilton Los Angeles Airport Thank you to our Content Partner: Medication Adherence AppleCare Pharmacy Programs Confidential and proprietary.

More information

An estimated 23.6 million people in the United States,

An estimated 23.6 million people in the United States, Impact of Treatment Complexity on Adherence and Glycemic Control: An Analysis of Oral Antidiabetic Agents Michael Pollack, MS, Benjamin Chastek, MS, Setareh A. Williams, PhD, and Jane Moran, MD Abstract

More information

Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star

Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star HEALTH ALLIANCE PLAN Presented by Vanita K. Pindolia, Pharm.D. VP, Ambulatory Clinical Pharmacy Programs_PCM Medicare 5-Star Rating

More information

Abstract. Non-Compliance to Antihypertensive Treatment among Patients Attending Prince Zaid Military Hospital

Abstract. Non-Compliance to Antihypertensive Treatment among Patients Attending Prince Zaid Military Hospital Non-Compliance to Antihypertensive Treatment among Patients Attending Prince Zaid Military Hospital Lana Sati Goussous (1) Nashat Ayoub Halasah (1) Manhal Halasa (2) (1) Royal medical Services, Jordan

More information

SPECIAL ISSUE. Medicaid Prescription Drug Access Restrictions: Exploring the Effect on Patient Persistence With Hypertension Medications

SPECIAL ISSUE. Medicaid Prescription Drug Access Restrictions: Exploring the Effect on Patient Persistence With Hypertension Medications Medicaid Prescription Drug Access Restrictions: Exploring the Effect on Patient Persistence With Hypertension Medications Jerome Wilson, PhD; Kirsten Axelsen, MS; and Simon Tang, MPH Objective: To compare

More information

Hypertension Update 2014:

Hypertension Update 2014: GSHTP Webinar Hypertension Update 2014: The Kaiser Permanente Northern California Experience Presented by: Marc Jaffe, MD Associate Clinical Professor of Medicine, UCSF Kaiser Permanente Northern California

More information

Addressing the Challenge of Medica3on Adherence. Jan Berger MD, MJ President and CEO Health Intelligence Partners

Addressing the Challenge of Medica3on Adherence. Jan Berger MD, MJ President and CEO Health Intelligence Partners Addressing the Challenge of Medica3on Adherence Jan Berger MD, MJ President and CEO Health Intelligence Partners Drugs Have Become the Mainstay of Healthcare Treatment America s Other Drug Problem Non-adherence

More information

Medication History. Case 1. Case 1. Case 2. Case 1. Four components of prescribing. Charles Mitchell

Medication History. Case 1. Case 1. Case 2. Case 1. Four components of prescribing. Charles Mitchell Medication History Charles Mitchell Director CSEP, University of Queensland Four components of prescribing Information gathering Clinical decision making Monitor and review Communicate decision - prescribe

More information

Primary prevention of Cardiovascular Diseases: Differences between European and United States Guidelines

Primary prevention of Cardiovascular Diseases: Differences between European and United States Guidelines 18 MEDICINSKI GLASNIK / str. 18-23 Vojislav Giga 1,2, Marija Petrović 1 Primary prevention of Cardiovascular Diseases: Differences between European and United States Guidelines Abstract: European Society

More information

EVALUATING THE IMPACT OF COST, PERCEIVED BENEFIT AND PERCEIVED VALUE ON PRESCRIPTION DRUG PURCHASING BEHAVIOR. Mahesh Jagannath Fuldeore

EVALUATING THE IMPACT OF COST, PERCEIVED BENEFIT AND PERCEIVED VALUE ON PRESCRIPTION DRUG PURCHASING BEHAVIOR. Mahesh Jagannath Fuldeore EVALUATING THE IMPACT OF COST, PERCEIVED BENEFIT AND PERCEIVED VALUE ON PRESCRIPTION DRUG PURCHASING BEHAVIOR Except where reference is made to the work of others, the work described in this thesis is

More information

Role of the Clinical Pharmacist in Primary Care

Role of the Clinical Pharmacist in Primary Care Role of the Clinical Pharmacist in Primary Care Amy Kramer, Pharm.D., Manager Clinical Pharmacy Services Kaiser Permanente Holly Miller, Pharm.D., BCACP, Primary Care Clinical Pharmacist Kaiser Permanente

More information

Panel Discussion: Orals Adherence & Challenges Friday, April 28 th, 2017

Panel Discussion: Orals Adherence & Challenges Friday, April 28 th, 2017 Panel Discussion: Orals Adherence & Challenges Friday, April 28 th, 2017 1 2017 Community Oncology Alliance Panel Discussion: Orals Adherence & Challenges Ray Bailey, RPh, Director of Pharmacy Florida

More information

The University of Mississippi School of Pharmacy

The University of Mississippi School of Pharmacy LONG TERM PERSISTENCE WITH ACEI/ARB THERAPY AFTER ACUTE MYOCARDIAL INFARCTION: AN ANALYSIS OF THE 2006-2007 MEDICARE 5% NATIONAL SAMPLE DATA Lokhandwala T. MS, Yang Y. PhD, Thumula V. MS, Bentley J.P.

More information

Medication Therapy Management: Improving Health and Saving Money

Medication Therapy Management: Improving Health and Saving Money Medication Therapy Management: Improving Health and Saving Money Ed Staffa, RPh Vice President, Pharmacy Mirixa Corporation estaffa@mirixa.com July 23, 2008 MTM At A Glance The U.S. health care system

More information

Literacy and Adherence

Literacy and Adherence Literacy and Adherence Michael Pignone, MD, MPH University of North Carolina-Chapel Hill Department of Medicine A Clinic Visit 54 y.o. woman with DM and HTN returns to clinic 3 months after your last visit

More information

outcome measures were adherence, medication possession ratio (MPR), persistence, prescription count, and duration of therapy.

outcome measures were adherence, medication possession ratio (MPR), persistence, prescription count, and duration of therapy. ORIGINAL RESEARCH Patient Adherence with HMG Reductase Inhibitor Therapy among Users of Two Types of Prescription Services by T. Jeffrey White, Pharm.D., M.S., Eunice Chang, Ph.D., Scott Leslie, M.P.H.,

More information

The Problem of CV Drug Adherence Worldwide

The Problem of CV Drug Adherence Worldwide The Problem of CV Drug Adherence Worldwide Jose M. Castellano Coordinador Investigaciones Clínicas, Centro Nacional de Investigaciones Cardiovascular (CNIC) Instituto de Salud Carlos III, Madrid, Spain

More information

Medicare Part D was implemented in 2006 to provide prescription

Medicare Part D was implemented in 2006 to provide prescription Effects of Coverage Gap Reform on Adherence to Diabetes Medications Feng Zeng, PhD; Bimal V. Patel, PharmD, MS; and Louis Brunetti, MD Objectives: To investigate the impact of Part D coverage gap reform

More information

Improvement of drug adherence using single pill combinations:

Improvement of drug adherence using single pill combinations: Improvement of drug adherence using single pill combinations: what is the evidence? Prof. Michel Burnier Service of Nephrology and Hypertension, CHUV, Lausanne, Switzerland Potentialcauses of non-adherence

More information

Circulation. 2009;119: ; originally published online January 12, 2009; doi: /CIRCULATIONAHA

Circulation. 2009;119: ; originally published online January 12, 2009; doi: /CIRCULATIONAHA Impact of a Prescription Copayment Increase on Lipid-Lowering Medication Adherence in Veterans Jalpa A. Doshi, Jingsan Zhu, Bruce Y. Lee, Stephen E. Kimmel and Kevin G. Volpp Circulation. 2009;119:390-397;

More information

Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands

Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands Objectives Identify patient barriers to medication adherence. Describe the clinical and economic impact of

More information

REDUCING COSTS AND IMPROVING HYPERTENSION MANAGEMENT

REDUCING COSTS AND IMPROVING HYPERTENSION MANAGEMENT REDUCING COSTS AND IMPROVING HYPERTENSION MANAGEMENT Vida Stankus 1, Brenda Hemmelgarn 2, Norm RC Campbell 2, Guanmin Chen 2, Finlay A McAlister 1, Ross T Tsuyuki 1 1 EPICORE Centre, Department of Medicine,

More information

Approximately one third of the 15.7 million Americans who are estimated to have diabetes

Approximately one third of the 15.7 million Americans who are estimated to have diabetes Diabetes is a very serious illness and too many people are neglecting their condition. Approximately one third of the 15.7 million Americans who are estimated to have diabetes are unaware of their condition.

More information

Despite advances in medical therapy, adherence to medications,

Despite advances in medical therapy, adherence to medications, ORIGINAL ARTICLE Patient, Physician, and Payment Predictors of Statin Adherence David C. Chan, MD,* William H. Shrank, MD, MSHS, David Cutler, PhD, Saira Jan, MS, PharmD, Michael A. Fischer, MD, MS, Jun

More information

NORTH CAROLINA STATE HEALTH PLAN FOR TEACHERS AND STATE EMPLOYEES

NORTH CAROLINA STATE HEALTH PLAN FOR TEACHERS AND STATE EMPLOYEES NORTH CAROLINA STATE HEALTH PLAN FOR TEACHERS AND STATE EMPLOYEES Using Clinical Risk Groups to Focus Board Strategic Initiatives July 26, 2013 Copyright 2013 by The Segal Group, Inc., parent of The Segal

More information

Applying Six Sigma Principles to Drive Healthcare Behavior Change:

Applying Six Sigma Principles to Drive Healthcare Behavior Change: Applying Six Sigma Principles to Drive Healthcare Behavior Change: Using Medication Compliance to Improve Healthcare Outcomes Presented by: Todd Prewitt, Director of Clinical Operations/Medical Director,

More information

Medicare Star Ratings and the Shift to Quality- Based Payment Models. David Nau, RPh, PhD, FAPhA PQS President

Medicare Star Ratings and the Shift to Quality- Based Payment Models. David Nau, RPh, PhD, FAPhA PQS President Medicare Star Ratings and the Shift to Quality- Based Payment Models David Nau, RPh, PhD, FAPhA PQS President The shift to Value-Driven Healthcare The U.S. health care system is rapidly moving to value-based

More information

D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine

D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine Financial Disclosure I have no relevant financial relationships

More information

Endocrinology: Patient Noncompliance vs. Provider Bias: A Clinical Revelation

Endocrinology: Patient Noncompliance vs. Provider Bias: A Clinical Revelation Endocrinology: Patient Noncompliance vs. Provider Bias: A Clinical Revelation Pamela Combs, MSN, BC-ANP, CDE 1 Case Study: Bobbi This is a case regarding a patient who presented to the Cleveland Clinic

More information

Exhibit 2 - YHP Plan Changes Service YHP Benefit Aetna Durable Medical Equipment including orthotics Prosthetic Devices Home Health Care $ 100 ded/80% to $ 5,000 annual maximum 100% up to $5,000 max Agreed

More information

9/25/15. Pharmacy Quality Measures: Financial Support. Learning Objectives. Speaker Disclosure. Access to Preferred Networks and Clinical Performance

9/25/15. Pharmacy Quality Measures: Financial Support. Learning Objectives. Speaker Disclosure. Access to Preferred Networks and Clinical Performance Pharmacy Quality Measures: Action Steps for Improvement Financial Support Financial support was provided for this activity through an unrestricted grant from Health Mart Systems, Inc. Christine Jacobson

More information

Behavioral Activation in the Treatment of Depression: An Effective and Efficient Model in the Primary Care Setting

Behavioral Activation in the Treatment of Depression: An Effective and Efficient Model in the Primary Care Setting Behavioral Activation in the Treatment of Depression: An Effective and Efficient Model in the Primary Care Setting Presenter Bob Davis, LMSW Claystone Clinical Associates Assistant Adjunct Professor Graduate

More information

PACIFICSOURCE COMMUNITY SOLUTIONS AND GORGE COORDINATED CARE ORGANIZATION. Chronic Pain and Opiate Management Initiatives

PACIFICSOURCE COMMUNITY SOLUTIONS AND GORGE COORDINATED CARE ORGANIZATION. Chronic Pain and Opiate Management Initiatives PACIFICSOURCE COMMUNITY SOLUTIONS AND GORGE COORDINATED CARE ORGANIZATION Chronic Pain and Opiate Management Initiatives Objectives To enhance understanding of current concepts, guidelines and risks of

More information

Condition/Procedure Measure Compliance Criteria Reference Attribution Method

Condition/Procedure Measure Compliance Criteria Reference Attribution Method Premium Specialty: Cardiology Credentialed Specialties include: Cardiac Diagnostic, Cardiology, Cardiovascular Disease, Clinical Cardiac Electrophysiology, and Interventional Cardiology This document is

More information

Medication Adherence and the Occurrence of Complications in Patients with Newly Diagnosed Hypertension

Medication Adherence and the Occurrence of Complications in Patients with Newly Diagnosed Hypertension Original Article Print ISSN 1738-5520 On-line ISSN 1738-5555 Korean Circulation Journal Medication Adherence and the Occurrence of Complications in Patients with Newly Diagnosed Hypertension Hyun-Jin Kim,

More information

Improving medication compliance with ingestible sensors

Improving medication compliance with ingestible sensors Improving medication compliance with ingestible sensors BHI 505: Digital Health Presentation By: Joseph Miles, PharmD Reference Moorhead, P., Zavala, A., Kim, Y., & Virdi, N. S. (2017). Science and Practice:

More information

Polypharmacy. A CPPE distance learning programme

Polypharmacy. A CPPE distance learning programme A CPPE distance learning programme DLP 177 January 2016 Contents About CPPE distance learning programmes About this learning programme Glossary of key terms v vii ix Contents Section 1 The problem with

More information

Safe, effective, affordable drug choices: online tool for payers and patients.

Safe, effective, affordable drug choices: online tool for payers and patients. Executive summary: Rising healthcare costs and greater access to medical information drive patients to seek options for their drug therapy. The MedAlternatives database by Gold Standard/Elsevier empowers

More information

Navigating The Prior Authorization Approval Process. Kristin Webb, RPCA University at Buffalo

Navigating The Prior Authorization Approval Process. Kristin Webb, RPCA University at Buffalo Navigating The Prior Authorization Approval Process Kristin Webb, RPCA University at Buffalo Disclosures DISCLOSURES Commercial Entity Relevance Role K. Webb Abbvie Merck, AbbVie, Tobira, Gilead Honorarium

More information

Navigating The Prior Authorization Approval Process

Navigating The Prior Authorization Approval Process Navigating The Prior Authorization Approval Process Kristin Webb, RPCA University at Buffalo Disclosures DISCLOSURES Commercial Entity Relevance Role K. Webb Abbvie Merck, AbbVie, Tobira, Gilead Honorarium

More information

Digital Technologies: The Solutions to Poor Medication Adherence?

Digital Technologies: The Solutions to Poor Medication Adherence? Digital Technologies: The Solutions to Poor Medication Adherence? Jeffrey Mesaros, PharmD Annual Meeting & Exposition Seattle, Washington March 22-25 1 Disclosures The views and opinions expressed in the

More information

MEDAN INTERNATIONAL CONFERENCE ON ADVANCE PHARMACEUTICAL SCIENCES 2014, NOVEMBER 3-4

MEDAN INTERNATIONAL CONFERENCE ON ADVANCE PHARMACEUTICAL SCIENCES 2014, NOVEMBER 3-4 MEDAN INTERNATIONAL CONFERENCE ON ADVANCE PHARMACEUTICAL SCIENCES 2014, NOVEMBER 3-4 Adherence to Prescribed Medications in Patients with Hypertension in Puskesmas Medan Oleh: Azizah Nasution Khairunnisa

More information

Addressing the Problem of Health Literacy: Practical Approaches in Practice

Addressing the Problem of Health Literacy: Practical Approaches in Practice Addressing the Problem of Health Literacy: Practical Approaches in Practice Darren DeWalt, MD, MPH & Michael Pignone, MD, MPH University of North Carolina-Chapel Hill Department of Medicine Topics Relationship

More information

Pediatric Adherence for the School Nurse

Pediatric Adherence for the School Nurse Pediatric Adherence for the School Nurse Eve-Lynn Nelson, Ph.D. Assistant Director, Research KU Center for TeleMedicine (913) 588-2413; enelson2@kumc.edu Generously sponsored through a grant from the Health

More information

Sujita Narayan. Research in Pharmacoepidemiology National School of Pharmacy, University of Otago

Sujita Narayan. Research in Pharmacoepidemiology National School of Pharmacy, University of Otago Sujita Narayan Research in Pharmacoepidemiology (RIPE) @ National School of Pharmacy, University of Otago Medication Possession Ratio (MPR) What is MPR? Measure of adherence Ratio of the no. of doses dispensed

More information

Barriers to Achieving A1C Targets: Clinical Inertia and Hypoglycemia. KM Pantalone Endocrinology

Barriers to Achieving A1C Targets: Clinical Inertia and Hypoglycemia. KM Pantalone Endocrinology Barriers to Achieving A1C Targets: Clinical Inertia and Hypoglycemia KM Pantalone Endocrinology Disclosures Speaker Bureau AstraZeneca, Merck, Novo Nordisk, Sanofi Consultant Novo Nordisk, Eli Lilly, Merck

More information

Noncompliance with Drug Therapy for Chronic Obstructive Pulmonary Disease: A Risk Factor for Hospitalization?

Noncompliance with Drug Therapy for Chronic Obstructive Pulmonary Disease: A Risk Factor for Hospitalization? Volume 2 Number 6 1999 VALUE IN HEALTH Noncompliance with Drug Therapy for Chronic Obstructive Pulmonary Disease: A Risk Factor for Hospitalization? Karl Matuszewski, MS, PharmD, 1 Palangat Velayudhan,

More information

The Un-Special World of Specialty Medications

The Un-Special World of Specialty Medications The Un-Special World of Specialty Medications Manpreet Chahal, PharmD, PhD Oncology Pharmacist, Medical Oncology Associates, Spokane WA Adjunct Clinical Instructor, WSU College of Pharmacy mschahal@wsu.edu

More information

Spending in the United States for prescription drugs was $216.7

Spending in the United States for prescription drugs was $216.7 Lipid Profile Changes Associated With Changing Available Formulary Statins: Removing Higher Potency Agents Daniel S. Longyhore, PharmD; Casey McNulty Stockton, PharmD; and Marie Roke Thomas, PhD Spending

More information

Performance Outcomes: Measure & Metric Details

Performance Outcomes: Measure & Metric Details Performance Outcomes: Measure & Metric Details Adherence to Antipsychotic Medications for People with Schizophrenia Numerator: Number of people who remained on an antipsychotic for at least 80% of their

More information

Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost

Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost Medical Care. 2005;43:521-530. Presented by Rodger Kormylo to the ACSW 11/10/2005 Medco is a registered trademark of Medco Health

More information

The American healthcare system, particularly the managed

The American healthcare system, particularly the managed REPORTS Collaborative Care and Motivational Interviewing: Improving Depression Outcomes Through Patient Empowerment Interventions Bill Anderson, PharmD The American healthcare system, particularly the

More information

Nonadherence to chronic medications contributes to

Nonadherence to chronic medications contributes to BRIEF REPORT Pharmacy-based Interventions to Reduce Primary Medication Nonadherence to Cardiovascular Medications Michael A. Fischer, MD, MS,* Niteesh K. Choudhry, MD, PhD,* Katsiaryna Bykov, PharmD, MS,*

More information

Guideline scope Hypertension in adults (update)

Guideline scope Hypertension in adults (update) NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Hypertension in adults (update) This guideline will update the NICE guideline on hypertension in adults (CG127). The guideline will be

More information